CXCL9 and neoplasm: LIF blockade results in TAM phenotypic changes, in which C-X-C motif chemokine ligand 9 (CXCL9) expression is elevated, and CD8+ T cells are recruited to the tumor, suggesting that LIF is involved in resistance to immune checkpoint blockade.